DEFIBROTIDE: A MAJOR BREAKTHROUGH TO FIGHT VENOOCCLUSIVE DISEASE (VOD) OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 2

Abstract

Venoocclusive disease (VOD) is a serious drawback of the standard Hematopoietic stem cell transplantation (HSCT) therapy. Day+ 100 survival of VOD patients after HSCT is very low (about 20%).[1] Previously the standard treatment for VOD was prophylactic and supportive which showed low evidence of effectiveness and high risk of adverse effects.[5] Recently, FDA approved the first therapy, Defibrotide for the treatment of this severe, rare and life-threatening hepatic VOD on March 30, 2016. Defibrotide was approved for the treatment of adult and pediatric patients suffering from hepatic veno-occlusive disease (VOD) with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).[10] Defibrotide increases tissue plasminogen activator (t-PA) and increases protection of activated endothelial cells from being damaged by chemotherapy, tumor necrosis factor-α (TNF-α), serum starvation and perfusion.[11]

Authors and Affiliations

Kedar G. Bandekar

Keywords

Related Articles

EFFECT OF DICLOFENAC ON THE PHARMACOKINETICS OF SULPHADIMIDINE IN WEST AFRICAN DWARF (WAD) GOATS FOLLOWING INTRAMUSCULAR ADMINISTRATION.

Sulphadimidine an antimicrobial is widely used in veterinary medicine in the treatment of animal diseases. It can be combined with non-steroidal anti-inflammatory drugs to treat various systemic infections associated wit...

FORMULATION SPAN 40 NIOSOME OF AQUEOUS FRACTION MENIRAN (PHYLLANTHUS NIRURI L.)

Meniran (Phyllanthus niruri L.) is used for many conditions such as diabetes mellitus, hypertension, obesity and hyperlipidemia. The active constituens to which the antidiabetic activity of P. niruri L. has been attribut...

SERUM PROCALCITONIN CONCENTRATION VS. TOTAL AND DIFFERENTIAL WHITE BLOOD CELL COUNT IN IRAQI BURN INJURY PATIENTS

White Blood Cell (WBC) count is an important test because it is easily available, and inexpensive laboratory marker already in use all over the world. Microbiological cultures of burn injury require time and among the ne...

ISOLATION AND IDENTIFICATION OF LACTOBACILLUS REUTERI FROM HUMAN BREAST MILK COLLECTED IN BAGHDAD

For many decades, breast milk has been regarded as a sterile body fluid which exerts its influence on the infant's microbiota environment via presenting only some growth factors and optimal conditions for helping the gro...

THE EVALUATION OF BANDAGE CONTACT LENSES AS A PRIMARY TREATMENT FOR TRAUMATIC CORNEAL ABRASIONS

Background: Corneal abrasions are a common result of eye trauma. Corneal injuries are very common in both the adult and paediatric population and account for a significant proportion of the workload of most emergency dep...

Download PDF file
  • EP ID EP628124
  • DOI -
  • Views 150
  • Downloads 0

How To Cite

Kedar G. Bandekar (2017). DEFIBROTIDE: A MAJOR BREAKTHROUGH TO FIGHT VENOOCCLUSIVE DISEASE (VOD) OF HEMATOPOIETIC STEM CELL TRANSPLANTATION. European Journal of Biomedical and Pharmaceutical Sciences, 4(2), 167-170. https://europub.co.uk/articles/-A-628124